IN2014MU01128A - - Google Patents

Download PDF

Info

Publication number
IN2014MU01128A
IN2014MU01128A IN1128MU2014A IN2014MU01128A IN 2014MU01128 A IN2014MU01128 A IN 2014MU01128A IN 1128MU2014 A IN1128MU2014 A IN 1128MU2014A IN 2014MU01128 A IN2014MU01128 A IN 2014MU01128A
Authority
IN
India
Prior art keywords
composition containing
maturation
delaying
diabetes
administering
Prior art date
Application number
Other languages
English (en)
Inventor
Deshpande Dr Jayant
J Shankaranarayanan
Original Assignee
Omniactive Health Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA2943921A priority Critical patent/CA2943921A1/en
Priority to AU2015237806A priority patent/AU2015237806A1/en
Priority to IN1128MU2014 priority patent/IN2014MU01128A/en
Priority to EP15717249.5A priority patent/EP3122339A2/en
Priority to KR1020167030397A priority patent/KR20160140859A/ko
Priority to MX2016012625A priority patent/MX2016012625A/es
Priority to US15/300,210 priority patent/US20170143646A1/en
Priority to PCT/IB2015/052248 priority patent/WO2015145389A2/en
Application filed by Omniactive Health Technologies Ltd filed Critical Omniactive Health Technologies Ltd
Priority to SG11201607996SA priority patent/SG11201607996SA/en
Priority to JP2017501531A priority patent/JP2017511380A/ja
Priority to CN201580017290.3A priority patent/CN106163536A/zh
Publication of IN2014MU01128A publication Critical patent/IN2014MU01128A/en
Priority to IL248016A priority patent/IL248016A0/en
Priority to PH12016501914A priority patent/PH12016501914A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
IN1128MU2014 2014-03-28 2015-03-26 IN2014MU01128A (es)

Priority Applications (13)

Application Number Priority Date Filing Date Title
US15/300,210 US20170143646A1 (en) 2014-03-28 2015-03-26 Effect of lipophilic nutrients on diabetic eye diseases
IN1128MU2014 IN2014MU01128A (es) 2014-03-28 2015-03-26
EP15717249.5A EP3122339A2 (en) 2014-03-28 2015-03-26 Effect of lipophilic nutrients on diabetic eye diseases
KR1020167030397A KR20160140859A (ko) 2014-03-28 2015-03-26 당뇨성 안질환에 대한 친지질성 영양소의 효과
MX2016012625A MX2016012625A (es) 2014-03-28 2015-03-26 Efecto de nutrientes lipofilicos en enfermedades de ojo diabetico.
CA2943921A CA2943921A1 (en) 2014-03-28 2015-03-26 Effect of lipophilic nutrients on diabetic eye diseases
PCT/IB2015/052248 WO2015145389A2 (en) 2014-03-28 2015-03-26 Effect of lipophilic nutrients on diabetic eye diseases
AU2015237806A AU2015237806A1 (en) 2014-03-28 2015-03-26 Effect of lipophilic nutrients on diabetic eye diseases
SG11201607996SA SG11201607996SA (en) 2014-03-28 2015-03-26 Effect of lipophilic nutrients on diabetic eye diseases
JP2017501531A JP2017511380A (ja) 2014-03-28 2015-03-26 脂溶性栄養素の糖尿病性眼疾患への効果
CN201580017290.3A CN106163536A (zh) 2014-03-28 2015-03-26 亲脂性营养素对糖尿病性眼病的作用
IL248016A IL248016A0 (en) 2014-03-28 2016-09-25 Effect of lipophilic nutrients on diabetic eye disease
PH12016501914A PH12016501914A1 (en) 2014-03-28 2016-09-27 Effect of lipophilic nutrients on diabetic eye diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1128MU2014 IN2014MU01128A (es) 2014-03-28 2015-03-26

Publications (1)

Publication Number Publication Date
IN2014MU01128A true IN2014MU01128A (es) 2015-10-02

Family

ID=54196517

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1128MU2014 IN2014MU01128A (es) 2014-03-28 2015-03-26

Country Status (13)

Country Link
US (1) US20170143646A1 (es)
EP (1) EP3122339A2 (es)
JP (1) JP2017511380A (es)
KR (1) KR20160140859A (es)
CN (1) CN106163536A (es)
AU (1) AU2015237806A1 (es)
CA (1) CA2943921A1 (es)
IL (1) IL248016A0 (es)
IN (1) IN2014MU01128A (es)
MX (1) MX2016012625A (es)
PH (1) PH12016501914A1 (es)
SG (1) SG11201607996SA (es)
WO (1) WO2015145389A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017137294A (ja) * 2016-01-29 2017-08-10 静岡県公立大学法人 ショウガ科植物抽出物送達用組成物
US20190125694A1 (en) * 2016-04-16 2019-05-02 Omniactive Health Technologies Limited Method for treatment of visual stress conditions and compositions used therein
US20180168182A1 (en) * 2016-12-21 2018-06-21 Muhammed Majeed Chewable compositions containing curcuminoids and their method of preparation
WO2019050542A1 (en) * 2017-09-11 2019-03-14 Verdure Sciences METHODS AND COMPOSITIONS FOR THE TREATMENT OF RETINAL, NEUROLOGICAL DISEASES AND OTHER ASSOCIATED DISEASES
CN108421020A (zh) * 2018-05-29 2018-08-21 李玉梅 一种用于治疗糖尿病视网膜病的生姜提取物及其制备方法和用途
US11135179B1 (en) 2018-12-28 2021-10-05 QH Holdings (Oregon), Inc. Eye health supplement
US11141386B1 (en) 2018-12-28 2021-10-12 QH Holdings (Oregon), Inc. Eye health supplement with curcumin
WO2020217258A1 (en) * 2019-04-26 2020-10-29 Jeyakodi Shankaranarayanan Bioaccessibile compositions of lipophilic compounds and process thereof
EP3967148A4 (en) * 2019-05-06 2022-12-21 Shenzhen Linpingxijing Vision Technology Co., Ltd EYE NOURISHING AND VISION ENHANCING HERBAL CANDY CONTAINING NUTRIENTS FOR HUMAN CRYSTALLINES AND RETINA PHOTOSENSITIVE CELLS
CN112006282A (zh) * 2020-09-04 2020-12-01 北京瑞济善健康科技有限公司 一种修复糖尿病并发症的组合物及其制备方法与应用
DE102022122731A1 (de) * 2022-09-07 2024-03-07 Ruma Gmbh Metabolisierbare Kontroll-Marker für die endogene Markierung von Urin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998753A (en) * 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
US6737535B2 (en) 2002-06-05 2004-05-18 Kancor Flavours And Extracts Limited Trans-lutein enriched xanthophyll ester concentrate and a process for its preparation
US6743953B2 (en) 2002-08-26 2004-06-01 Kancor Flavours & Extracts Ltd. Process for the preparation of xanthophyll crystals
US20060088574A1 (en) * 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
CN101686951A (zh) * 2006-11-13 2010-03-31 纽约市哥伦比亚大学托管会 治疗糖尿病的选择性蛋白酶体抑制物
US20080181972A1 (en) * 2007-01-29 2008-07-31 Valentina Amico Compositions and Methods for Maintaining, Strengthening, Improving, or Promoting Eye Health
US8163312B2 (en) 2008-09-22 2012-04-24 Innoveda Biological Solutions (P) Ltd. Herbal formulation for prevention and treatment of diabetes and associated complications
CA2760932A1 (en) 2009-05-04 2010-11-11 Thierry Nivaggioli Mtor pathway inhibitors for treating ocular disorders
HUE028031T2 (en) * 2009-09-02 2016-11-28 Omniactive Health Tech Ltd For the preparation of xanthophyll composition and method comprising macular pigments
US20110300246A1 (en) * 2010-06-03 2011-12-08 Qinheng Huang Herbal Extracts for Treatment of Diabetic Complications and Oxidative Stress
ES2774659T3 (es) 2010-09-24 2020-07-22 Omnivision Gmbh Composición que contiene SOD, luteína y zeaxantina
CN102178925A (zh) 2011-04-25 2011-09-14 崔晓廷 新型视力保护剂叶黄素眼用制剂
CN102225087A (zh) * 2011-06-09 2011-10-26 雷爱林 一种强效护眼的叶黄素复方制剂
MX2015013624A (es) * 2013-03-28 2016-06-10 Omniactive Health Technologies Ltd Efecto neuroprotector de carotenoides en el cerebro.
CN103238902B (zh) * 2013-05-23 2014-12-03 云南瑞宝生物科技有限公司 一种果珍及其制备方法

Also Published As

Publication number Publication date
MX2016012625A (es) 2017-01-09
CN106163536A (zh) 2016-11-23
AU2015237806A1 (en) 2016-10-20
CA2943921A1 (en) 2015-10-01
SG11201607996SA (en) 2016-11-29
PH12016501914A1 (en) 2017-01-09
US20170143646A1 (en) 2017-05-25
WO2015145389A2 (en) 2015-10-01
IL248016A0 (en) 2016-11-30
EP3122339A2 (en) 2017-02-01
KR20160140859A (ko) 2016-12-07
WO2015145389A3 (en) 2015-11-26
JP2017511380A (ja) 2017-04-20

Similar Documents

Publication Publication Date Title
IN2014MU01128A (es)
AR103260A1 (es) Modulación inmunitaria
PH12015502238A1 (en) Neuroprotective effect of carotenoids in brain
ECSP17043318A (es) Composición que contiene quitina y proteínas digeribles
BR112018008777A2 (pt) método para isolar uma fração enriquecida de moléculas de rna pequeno a partir de uma amostra de fungos e/ou plantas, moléculas de rna pequeno, alimento e/ou aditivo alimentar e/ou suplemento dietético e/ou produto nutracêutico, método para produzir um segundo alimento e/ou produto nutracêutico e composição farmacêutica ou cosmética
CL2017000475A1 (es) Composición para formulación cosmética que consiste en una mezcla de hasta 3 componentes seleccionados de manteca de murumuru, manteca de ucuuba, aceite de nuez de brasil, aceite de maracuyá, manteca de copoazú, aceite de acai y aceite de andiroba y/o ésteres de los mismos; producto cosmético.
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
BR112017013004A2 (pt) produto frito obtido a partir de uma composição para um produto frito, uso de uma farinha de microalgas como substituta da gordura e método de preparação de um produto frito
EP3197857A4 (en) Fatty acid composition and method for fortifying nutritional products with fatty acids
MX2016016995A (es) Composiciones de acido fitico, magnesio y polifenoles y su aplicacion para la prevencion de la litiasis renal oxalocalcica.
NZ733322A (en) Grape products for nonalcoholic fatty liver disease and other uses
EP3185695A4 (en) Preparation of soy protein products ("s810")
BR112017006779A2 (pt) composição farmacêutica oral de baixa dose seu processo de preparação e método de tratamento
WO2016080796A3 (ko) 세스퀴테르펜 화합물을 포함하는, stat3 매개 질환의 예방 또는 치료용 약학적 조성물 및 이의 용도
CR20150478A (es) Método para el tratamiento y control de enfermedades de postrecolección de frutas y hortalizas y composiciones que comprenden extractos naturales y formulaciones fitofortificantes y/o fungicidas para aplicar en dicho método.
BR112017003945A2 (pt) composição de gordura comestível
NZ713235A (en) Product and method for improving bioavailability of therapeutic compounds
PH12017500203B1 (en) Nutritional composition for use in promoting gut and/or liver maturation and/or repair
EP3220933A4 (en) Method of increasing levels of omega-3 fatty acids in beef products by administration of a grass and algae diet
NZ761512A (en) Prevention and/or treatment of neurodegenerative disease
MX2017007230A (es) Composiciones y metodos que comprenden trigliceridos de cadena media para el tratamiento de la epilepsia.
PH12017500740A1 (en) Nutritional supplements containing a peptide component and uses thereof
BR112018008964A8 (pt) método para induzir saciedade
Santini et al. Nutraceuticals recovery from tomato processing waste and by-products: lycopene
ES2542163R2 (es) Procedimiento de obtención de granos de arroz integral germinado y productos derivados de los mismos que comprenden compuestos biológicamente activos